Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Universe Pharmaceuticals Inc

UPC
Current price
0.54 USD +0.03 USD (+5.88%)
Last closed 0.52 USD
ISIN KYG9442G1047
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 1 430 162 USD
Yield for 12 month -98.68 %
1Y
3Y
5Y
10Y
15Y
UPC
21.11.2021 - 28.11.2021

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited. Address: 265, Jingjiu Avenue, Ji'An, China, 343100

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

+32 308 735 USD

Last Year

+40 143 151 USD

Current Quarter

+12 884 370 USD

Last Quarter

+13 841 549 USD

Current Year

+10 315 134 USD

Last Year

+21 891 336 USD

Current Quarter

+3 244 626 USD

Last Quarter

+4 063 370 USD

Key Figures UPC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -4 916 293 USD
Operating Margin TTM -13.51 %
PE Ratio
Return On Assets TTM -5.65 %
PEG Ratio
Return On Equity TTM -50.22 %
Wall Street Target Price
Revenue TTM 26 725 920 USD
Book Value 7.34 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -30.20 %
Dividend Yield
Gross Profit TTM 21 891 336 USD
Earnings per share -76.35 USD
Diluted Eps TTM -76.35 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -82.00 %
Profit Margin -69.41 %

Dividend Analytics UPC

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History UPC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 18.11.2024
Dividend Date

Stock Valuation UPC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.017
Price Sales TTM 0.054
Enterprise Value EBITDA 0.31
Price Book MRQ 0.054

Financials UPC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators UPC

For 52 weeks

0.63 USD 64.80 USD
50 Day MA 3.37 USD
Shares Short Prior Month 37 219
200 Day MA 28.13 USD
Short Ratio 0.38
Shares Short 21 234
Short Percent 1.48 %